0000950103-19-006626.txt : 20190521 0000950103-19-006626.hdr.sgml : 20190521 20190521141532 ACCESSION NUMBER: 0000950103-19-006626 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20190521 FILED AS OF DATE: 20190521 DATE AS OF CHANGE: 20190521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mereo Biopharma Group plc CENTRAL INDEX KEY: 0001719714 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38452 FILM NUMBER: 19841880 BUSINESS ADDRESS: STREET 1: ONE CAVENDISH PLACE STREET 2: FOURTH FLOOR CITY: LONDON STATE: X0 ZIP: W1G0QF BUSINESS PHONE: 4403330237300 MAIL ADDRESS: STREET 1: ONE CAVENDISH PLACE STREET 2: FOURTH FLOOR CITY: LONDON STATE: X0 ZIP: W1G0QF 6-K 1 dp107067_6k.htm FORM 6-K

 

 

 UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 or 15d-16 UNDER THE 

SECURITIES EXCHANGE ACT OF 1934

 

For the month of May, 2019

 

Commission File Number: 001-38452

 

MEREO BIOPHARMA GROUP PLC

(Translation of registrant’s name into English)

 

4th Floor, One Cavendish Place,

London, W1G 0QF, United Kingdom

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x  Form 40-F ¨ 

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨ 

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨ 

 

 

 

 

 

Mereo BioPharma Group plc

 

 ("Mereo" or the "Company")

 

Notification of Director and other PDMR Dealings

 

London, May 21, 2019 - Mereo BioPharma Group plc (AIM: MPH, NASDAQ: MREO), a clinical stage UK based biopharmaceutical company focused on rare diseases, on May 20, 2019 granted incentive awards as set out below to persons discharging managerial responsibilities (PDMRs). All the awards were granted for nil consideration and shall ordinarily be forfeit (to the extent unvested) upon cessation of service.

 

Options to acquire American Depositary Shares (“ADSs”) at an exercise price of $5.40 per ADS (Fair Market Value at grant) under the Mereo BioPharma Group plc 2019 Equity Incentive Plan (an employees’ share scheme):

 

Name of PDMR Position Number of ADSs over which Option granted
Denise Scots-Knight Chief Executive Officer 87,500
Alastair MacKinnon Chief Medical Officer 27,500
Richard Jones Chief Financial Officer 27,500
Charles Sermon General Counsel 27,500
Wills Hughes-Wilson Head of Patient Access and Commercial Planning 18,000
John Richard Head of Corporate Development 27,500
     

These Options shall normally vest and become exercisable as to one quarter on the first anniversary of their grant date and, thereafter, as to the balance in equal monthly installments over the three-year period following such anniversary.

 

Awards to either acquire ADSs at an exercise price of $5.40 per ADS (Fair Market Value at grant) or, at the Company’s discretion, receive a cash amount equal to the excess, if any, over the exercise price of their Fair Market Value on the exercise date:

 

Name of PDMR Position Number of ADSs over which Award granted
Peter Fellner Chairman 5,500
Anders Ekblom Director 5,500
Peter Bains Director 5,500
Kunal Kashyap Director 5,500
Paul Blackburn Director 5,500
Deepa Pakianathan Director 5,500
Michael Wyzga Director 5,500
     

These awards shall vest in equal monthly installments over the year following their grant date.

 

The below announcement and notification is made in accordance with the EU Market Abuse Regulation. The forms required under the EU Market Abuse Regulation follow.

 

1 Details of the person discharging managerial responsibilities
a) Name Denise Scots-Knight
2 Reason for the notification
a) Position/status Chief Executive Officer

 

 

b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Mereo BioPharma Group plc
b) LEI 213800U8JQHIJOS5AS09
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code AMERICAN DEPOSITARY SHARE (ADS), EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF GBP0.003 EACH
b) Nature of the transaction GRANT OF AN OPTION (FOR NO CONSIDERATION) UNDER THE MEREO BIOPHARMA GROUP PLC 2019 EQUITY INCENTIVE PLAN. THE EXERCISE PRICE IS US$5.40 PER ADS (FAIR MARKET VALUE AT GRANT)
c) Price(s) and volume(s)

 

d) Aggregated information:  volume, Price NOT APPLICABLE – SINGLE TRANSACTION
e) Date of the transaction May 20, 2019
f) Place of the transaction Outside of a trading venue

 

 

1 Details of the person discharging managerial responsibilities
a) Name Alastair MacKinnon
2 Reason for the notification
a) Position/status Chief Medical Officer
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Mereo BioPharma Group plc

 

 

b) LEI 213800U8JQHIJOS5AS09
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code AMERICAN DEPOSITARY SHARE (ADS), EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF GBP0.003 EACH
b) Nature of the transaction GRANT OF AN OPTION (FOR NO CONSIDERATION) UNDER THE MEREO BIOPHARMA GROUP PLC 2019 EQUITY INCENTIVE PLAN. THE EXERCISE PRICE IS US$5.40 PER ADS (FAIR MARKET VALUE AT GRANT)
c) Price(s) and volume(s)

 

  

 

d) Aggregated information:  volume, Price NOT APPLICABLE – SINGLE TRANSACTION
e) Date of the transaction May 20, 2019
f) Place of the transaction Outside of a trading venue

 

 

1 Details of the person discharging managerial responsibilities
a) Name Richard Jones
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Mereo BioPharma Group plc
b) LEI 213800U8JQHIJOS5AS09
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and AMERICAN DEPOSITARY SHARE (ADS), EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF

 

 

  identification code GBP0.003 EACH
b) Nature of the transaction GRANT OF AN OPTION (FOR NO CONSIDERATION) UNDER THE MEREO BIOPHARMA GROUP PLC 2019 EQUITY INCENTIVE PLAN. THE EXERCISE PRICE IS US$5.40 PER ADS (FAIR MARKET VALUE AT GRANT)
c) Price(s) and volume(s)

 

d) Aggregated information:  volume, Price NOT APPLICABLE – SINGLE TRANSACTION
e) Date of the transaction May 20, 2019
f) Place of the transaction Outside of a trading venue

 

 

1 Details of the person discharging managerial responsibilities
a) Name Charles Sermon
2 Reason for the notification
a) Position/status General Counsel
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Mereo BioPharma Group plc
b) LEI 213800U8JQHIJOS5AS09
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code AMERICAN DEPOSITARY SHARE (ADS), EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF GBP0.003 EACH
b) Nature of the transaction GRANT OF AN OPTION (FOR NO CONSIDERATION) UNDER THE MEREO BIOPHARMA GROUP PLC 2019 EQUITY INCENTIVE PLAN. THE EXERCISE PRICE IS US$5.40 PER ADS (FAIR MARKET VALUE AT GRANT)

 

 

c) Price(s) and volume(s)

 

d) Aggregated information:  volume, Price NOT APPLICABLE – SINGLE TRANSACTION
e) Date of the transaction May 20, 2019
f) Place of the transaction Outside of a trading venue

 

 

1 Details of the person discharging managerial responsibilities
a) Name Wills Hughes-Wilson
2 Reason for the notification
a) Position/status Head of Patient Access and Commercial Planning
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Mereo BioPharma Group plc
b) LEI 213800U8JQHIJOS5AS09
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code AMERICAN DEPOSITARY SHARE (ADS), EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF GBP0.003 EACH
b) Nature of the transaction GRANT OF AN OPTION (FOR NO CONSIDERATION) UNDER THE MEREO BIOPHARMA GROUP PLC 2019 EQUITY INCENTIVE PLAN. THE EXERCISE PRICE IS US$5.40 PER ADS (FAIR MARKET VALUE AT GRANT)
c) Price(s) and volume(s)

 

d) Aggregated information:  volume, NOT APPLICABLE – SINGLE TRANSACTION

 

 

  Price  
e) Date of the transaction May 20, 2019
f) Place of the transaction Outside of a trading venue

 

 

1 Details of the person discharging managerial responsibilities
a) Name John Richard
2 Reason for the notification
a) Position/status Head of Corporate Development
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Mereo BioPharma Group plc
b) LEI 213800U8JQHIJOS5AS09
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code AMERICAN DEPOSITARY SHARE (ADS), EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF GBP0.003 EACH
b) Nature of the transaction GRANT OF AN OPTION (FOR NO CONSIDERATION) UNDER THE MEREO BIOPHARMA GROUP PLC 2019 EQUITY INCENTIVE PLAN. THE EXERCISE PRICE IS US$5.40 PER ADS (FAIR MARKET VALUE AT GRANT)
c) Price(s) and volume(s)

 

d) Aggregated information:  volume, Price NOT APPLICABLE – SINGLE TRANSACTION
e) Date of the transaction May 20, 2019
f) Place of the transaction Outside of a trading venue

 

 

1 Details of the person discharging managerial responsibilities
a) Name Peter Fellner
2 Reason for the notification
a) Position/status Chairman
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Mereo BioPharma Group plc
b) LEI 213800U8JQHIJOS5AS09
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code AMERICAN DEPOSITARY SHARE (ADS), EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF GBP0.003 EACH
b) Nature of the transaction GRANT OF AN AWARD (FOR NO CONSIDERATION) UNDER THE MEREO BIOPHARMA GROUP PLC 2019 NON-EMPLOYEE EQUITY INCENTIVE PLAN. THE EXERCISE PRICE IS US$5.40 PER ADS (FAIR MARKET VALUE AT GRANT). ON EXERCISE, THE COMPANY HAS DISCRETION EITHER TO DELIVER ADSS OR MAKE A CASH PAYMENT EQUAL TO ANY EXCESS OF THEIR FAIR MARKET VALUE OVER THE EXERCISE PRICE
c) Price(s) and volume(s)

 

d) Aggregated information:  volume, Price NOT APPLICABLE – SINGLE TRANSACTION
e) Date of the transaction May 20, 2019
f) Place of the transaction Outside of a trading venue

 

 

1 Details of the person discharging managerial responsibilities
a) Name Anders Ekblom

 

 

2 Reason for the notification
a) Position/status Director
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Mereo BioPharma Group plc
b) LEI 213800U8JQHIJOS5AS09
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code AMERICAN DEPOSITARY SHARE (ADS), EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF GBP0.003 EACH
b) Nature of the transaction GRANT OF AN AWARD (FOR NO CONSIDERATION) UNDER THE MEREO BIOPHARMA GROUP PLC 2019 NON-EMPLOYEE EQUITY INCENTIVE PLAN. THE EXERCISE PRICE IS US$5.40 PER ADS (FAIR MARKET VALUE AT GRANT). ON EXERCISE, THE COMPANY HAS DISCRETION EITHER TO DELIVER ADSS OR MAKE A CASH PAYMENT EQUAL TO ANY EXCESS OF THEIR FAIR MARKET VALUE OVER THE EXERCISE PRICE
c) Price(s) and volume(s)

 

d) Aggregated information:  volume, Price NOT APPLICABLE – SINGLE TRANSACTION
e) Date of the transaction May 20, 2019
f) Place of the transaction Outside of a trading venue

 

 

1 Details of the person discharging managerial responsibilities
a) Name Peter Bains
2 Reason for the notification
a) Position/status Director

 

 

b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Mereo BioPharma Group plc
b) LEI 213800U8JQHIJOS5AS09
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code AMERICAN DEPOSITARY SHARE (ADS), EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF GBP0.003 EACH
b) Nature of the transaction GRANT OF AN AWARD (FOR NO CONSIDERATION) UNDER THE MEREO BIOPHARMA GROUP PLC 2019 NON-EMPLOYEE EQUITY INCENTIVE PLAN. THE EXERCISE PRICE IS US$5.40 PER ADS (FAIR MARKET VALUE AT GRANT). ON EXERCISE, THE COMPANY HAS DISCRETION EITHER TO DELIVER ADSS OR MAKE A CASH PAYMENT EQUAL TO ANY EXCESS OF THEIR FAIR MARKET VALUE OVER THE EXERCISE PRICE
c) Price(s) and volume(s)

d) Aggregated information:  volume, Price NOT APPLICABLE – SINGLE TRANSACTION
e) Date of the transaction May 20, 2019
f) Place of the transaction Outside of a trading venue

 

 

1 Details of the person discharging managerial responsibilities
a) Name Kunal Kashyap
2 Reason for the notification
a) Position/status Director
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or

 

 

  auction monitor
a) Name Mereo BioPharma Group plc
b) LEI 213800U8JQHIJOS5AS09
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code AMERICAN DEPOSITARY SHARE (ADS), EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF GBP0.003 EACH
b) Nature of the transaction GRANT OF AN AWARD (FOR NO CONSIDERATION) UNDER THE MEREO BIOPHARMA GROUP PLC 2019 NON-EMPLOYEE EQUITY INCENTIVE PLAN. THE EXERCISE PRICE IS US$5.40 PER ADS (FAIR MARKET VALUE AT GRANT). ON EXERCISE, THE COMPANY HAS DISCRETION EITHER TO DELIVER ADSS OR MAKE A CASH PAYMENT EQUAL TO ANY EXCESS OF THEIR FAIR MARKET VALUE OVER THE EXERCISE PRICE
c) Price(s) and volume(s)

 

d) Aggregated information:  volume, Price NOT APPLICABLE – SINGLE TRANSACTION
e) Date of the transaction May 20, 2019
f) Place of the transaction Outside of a trading venue

 

 

1 Details of the person discharging managerial responsibilities
a) Name Paul Blackburn
2 Reason for the notification
a) Position/status Director
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Mereo BioPharma Group plc

 

 

b) LEI 213800U8JQHIJOS5AS09
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code AMERICAN DEPOSITARY SHARE (ADS), EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF GBP0.003 EACH
b) Nature of the transaction GRANT OF AN AWARD (FOR NO CONSIDERATION) UNDER THE MEREO BIOPHARMA GROUP PLC 2019 NON-EMPLOYEE EQUITY INCENTIVE PLAN. THE EXERCISE PRICE IS US$5.40 PER ADS (FAIR MARKET VALUE AT GRANT). ON EXERCISE, THE COMPANY HAS DISCRETION EITHER TO DELIVER ADSS OR MAKE A CASH PAYMENT EQUAL TO ANY EXCESS OF THEIR FAIR MARKET VALUE OVER THE EXERCISE PRICE
c) Price(s) and volume(s)

 

d) Aggregated information:  volume, Price NOT APPLICABLE – SINGLE TRANSACTION
e) Date of the transaction May 20, 2019
f) Place of the transaction Outside of a trading venue

 

 

1 Details of the person discharging managerial responsibilities
a) Name Deepa Pakianathan
2 Reason for the notification
a) Position/status Director
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Mereo BioPharma Group plc
b) LEI 213800U8JQHIJOS5AS09
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a) Description of the financial instrument, type of instrument and identification code AMERICAN DEPOSITARY SHARE (ADS), EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF GBP0.003 EACH
b) Nature of the transaction GRANT OF AN AWARD (FOR NO CONSIDERATION) UNDER THE MEREO BIOPHARMA GROUP PLC 2019 NON-EMPLOYEE EQUITY INCENTIVE PLAN. THE EXERCISE PRICE IS US$5.40 PER ADS (FAIR MARKET VALUE AT GRANT). ON EXERCISE, THE COMPANY HAS DISCRETION EITHER TO DELIVER ADSS OR MAKE A CASH PAYMENT EQUAL TO ANY EXCESS OF THEIR FAIR MARKET VALUE OVER THE EXERCISE PRICE
c) Price(s) and volume(s)

 

d) Aggregated information:  volume, Price NOT APPLICABLE – SINGLE TRANSACTION
e) Date of the transaction May 20, 2019
f) Place of the transaction Outside of a trading venue

 

 

1 Details of the person discharging managerial responsibilities
a) Name Michael Wyzga
2 Reason for the notification
a) Position/status Director
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Mereo BioPharma Group plc
b) LEI 213800U8JQHIJOS5AS09
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code AMERICAN DEPOSITARY SHARE (ADS), EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF GBP0.003 EACH

 

 

b) Nature of the transaction GRANT OF AN AWARD (FOR NO CONSIDERATION) UNDER THE MEREO BIOPHARMA GROUP PLC 2019 NON-EMPLOYEE EQUITY INCENTIVE PLAN. THE EXERCISE PRICE IS US$5.40 PER ADS (FAIR MARKET VALUE AT GRANT). ON EXERCISE, THE COMPANY HAS DISCRETION EITHER TO DELIVER ADSS OR MAKE A CASH PAYMENT EQUAL TO ANY EXCESS OF THEIR FAIR MARKET VALUE OVER THE EXERCISE PRICE
c) Price(s) and volume(s)

 

d) Aggregated information:  volume, Price NOT APPLICABLE – SINGLE TRANSACTION
e) Date of the transaction May 20, 2019
f) Place of the transaction Outside of a trading venue

 

 

 

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: May 21, 2019

 

  MEREO BIOPHARMA GROUP PLC
   
   
   
  By: /s/ Charles Sermon
    Name:   Charles Sermon
    Title:     General Counsel

 

 

 

 

 

 

 GRAPHIC 2 image_001.jpg GRAPHIC begin 644 image_001.jpg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end GRAPHIC 3 image_002.jpg GRAPHIC begin 644 image_002.jpg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end GRAPHIC 4 image_003.jpg GRAPHIC begin 644 image_003.jpg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end GRAPHIC 5 image_004.jpg GRAPHIC begin 644 image_004.jpg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end GRAPHIC 6 image_005.jpg GRAPHIC begin 644 image_005.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#V._\ $4EK MK,FEVFB:EJ,\5O'<2M:M JHLC2*H/FRH27"_.;?YL3,J\ M?7/- '0?\)#JG_0F:Y_W^LO_ )(H_P"$AU3_ *$S7/\ O]9?_)%XEBDECVPR*&.SS 2[-(O1@!@\=J .F_P"$AU3_ *$S7/\ O]9?_)%' M_"0ZI_T)FN?]_K+_ .2*Y[6_&>O:?J;:9!9PM?6FGI=7,<%A=7BW$KE@(D:( M#RA^[;YW!^\.#M.;7]HW]WJ&O:O::>\]]IUC%#964HP5=XQ*_7'S'SDC9$\Q-\,V67)#+D,0REAZBN^@E$]O', 0)$# 'MD9 MH P_^$AU3_H3-<_[_67_ ,D4?\)#JG_0F:Y_W^LO_DBN@HH Y_\ X2'5/^A, MUS_O]9?_ "11_P )#JG_ $)FN?\ ?ZR_^2*Z"B@#G_\ A(=4_P"A,US_ +_6 M7_R11_PD.J?]"9KG_?ZR_P#DBN@HH Y__A(=4_Z$S7/^_P!9?_)%'_"0ZI_T M)FN?]_K+_P"2*Z"B@#G_ /A(=4_Z$S7/^_UE_P#)%'_"0ZI_T)FN?]_K+_Y( MKH** .?_ .$AU3_H3-<_[_67_P D4?\ "0ZI_P!"9KG_ '^LO_DBN@HH Y__ M (2'5/\ H3-<_P"_UE_\D4?\)#JG_0F:Y_W^LO\ Y(KH** .?_X2'5/^A,US M_O\ 67_R11_PD.J?]"9KG_?ZR_\ DBN@HH Y=/%]W)J,U@OA'7#=0Q1S2)YE MG\J.7"G/VC')C?\ +W%6/^$AU3_H3-<_[_67_P D46?_ "4/6?\ L%6'_HV[ MJCXG5=*\5^'?$.0D7F/IEVYX'ES %"3Z"5$'_ Z +W_"0ZI_T)FN?]_K+_Y( MH_X2'5/^A,US_O\ 67_R17+:'J-[#965[8K!'J?B_4Y;E)[J-G2&W6-FCRH9 M2Q\F) !E>7)[8-*_\3WLFI:=JTL-N-1TO3]I*'5N96DVE3@_=Q^/O4&H>*_%&ERZWYSZ/+'HS6\DI2UE4SQR MX^1.-5/B2[M[*P>>SL]0CLGMXM-N99)0=F^03K^Z3;OSL8$D(>1N&'_ M -I:E%8ZSKFGVIN+V;5C9-(;9IS;6T,ABR(D*O(H(=]JG.9&(SC! -W_ (2' M5/\ H3-<_P"_UE_\D4?\)#JG_0F:Y_W^LO\ Y(K$EUAKS1]%U]I;>2^M=52Q ME>WBDCRDLP@=&CD&]#RCE#G#(O)P">[H Y__ (2'5/\ H3-<_P"_UE_\D4?\ M)#JG_0F:Y_W^LO\ Y(KH** .?_X2'5/^A,US_O\ 67_R11_PD.J?]"9KG_?Z MR_\ DBN@HH Y_P#X2'5/^A,US_O]9?\ R11_PD.J?]"9KG_?ZR_^2*Z"B@#G M_P#A(=4_Z$S7/^_UE_\ )%'_ D.J?\ 0F:Y_P!_K+_Y(KH** .?_P"$AU3_ M *$S7/\ O]9?_)%'_"0ZI_T)FN?]_K+_ .2*Z"B@#G_^$AU3_H3-<_[_ %E_ M\D4?\)#JG_0F:Y_W^LO_ )(KH** .?\ ^$AU3_H3-<_[_67_ ,D4?\)#JG_0 MF:Y_W^LO_DBN@HH P[#Q%)=:S'I=WHFI:=/+;R7$3730,KK&T:L!Y4KD',J= M0.];E<_>?\E#T;_L%7__ *-M*Z"@#G[/_DH>L_\ 8*L/_1MW6K-IMI/J=KJ, ML.Z[M4DCADW$;5DV[QC.#G8O4=N*RK/_ )*'K/\ V"K#_P!&W==!0!4N],L[ MZZLKFXAWS64IFMVW$;'*LA. >?E9ASGK6?-X2T6:(I]FEC/VF2[$L%S+%(LL MF=Y5T8,H;)R 0/:MNB@#G[GP1X>NH+>%[!HXX+^$;?^ MQKO3-/WJNI.B7\]U=2SRO!T=0[EF.5RH&0%WD^H/2 # '0"EHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#G[/_DH>L_\ 8*L/_1MW6EK. MC:?X@TFXTO5+87-E< "6(L5W8((Y!!&" >#VK-L_^2AZS_V"K#_T;=UT% &= M?:%IVHZ?!8W$#""W96@\F5XGA*C *.A#*<$C((X)'0FH(O"VB0I:(E@FVTAF M@B#.S#9,09=V3\Y8J"2V23DYY.=BB@#FXO 7AN&VGMQ9321SVPM)/.O)I&,( M((0,SDA01P 1CG'4U?N_#>DWW]H?:;3?_:(C6Z_>./,$?W.AXQ[8]ZU:* ,6 MY\)Z+=ZJ=2FM&:X:1)743R+%(Z?<=X@VQV&!AF4D8'H*K_\ "+033:C;7B"3 M3KBZ6^MS',\4UO.1A]K)@J,C< /F.#QUZ*B@#GI/#,2'2[.T58]-MKHWMQ MYDKR2S2@Y3+-DM\YWEBVJ?:8KZ3S=*L=OV2PGN<8EN\Y\I&V]>^,\XZ&M#_A,M+_ .?77/\ MP17O_P 9HL_^2AZS_P!@JP_]&W==!0!S_P#PF6E_\^NN?^"*]_\ C-'_ F6 ME_\ /KKG_@BO?_C-=!10!S__ F6E_\ /KKG_@BO?_C-'_"9:7_SZZY_X(KW M_P",UT%% '/_ /"9:7_SZZY_X(KW_P",T?\ "9:7_P ^NN?^"*]_^,UT%% ' M/_\ "9:7_P ^NN?^"*]_^,T?\)EI?_/KKG_@BO?_ (S7044 <_\ \)EI?_/K MKG_@BO?_ (S1_P )EI?_ #ZZY_X(KW_XS705YYK.M:EHWQ'N[[[5*^B6EA:" M]M2Q*1I+),IG [%"B;O]C__&:/^$RT MO_GUUS_P17O_ ,9KH** .?\ ^$RTO_GUUS_P17O_ ,9H_P"$RTO_ )]=<_\ M!%>__&:Z"B@#G_\ A,M+_P"?77/_ 17O_QFC_A,M+_Y]=<_\$5[_P#&:Z"B M@#G_ /A,M+_Y]=<_\$5[_P#&:/\ A,M+_P"?77/_ 17O_QFN@HH Y__ (3+ M2_\ GUUS_P $5[_\9H_X3+2_^?77/_!%>_\ QFN@HH X.U\6:__&:YWQS/>R:V]M:7.H/Y M&D2SK;Z?_\ QFC_ (3+2_\ GUUS_P $5[_\ M9KE-0OKS1X/$&B6U[?-"M]I]O#/-3CGG)KHZ .?_P"$RTO_ )]=<_\ !%>__&:/^$RTO_GUUS_P17O_ M ,9KH** .?\ ^$RTO_GUUS_P17O_ ,9H_P"$RTO_ )]=<_\ !%>__&:Z"B@# MG_\ A,M+_P"?77/_ 17O_QFC_A,M+_Y]=<_\$5[_P#&:Z"B@#G_ /A,M+_Y M]=<_\$5[_P#&:/\ A,M+_P"?77/_ 17O_QFN@HH Y__ (3+2_\ GUUS_P $ M5[_\9H_X3+2_^?77/_!%>_\ QFN@HH Y_P#X3+2_^?77/_!%>_\ QFC_ (3+ M2_\ GUUS_P $5[_\9KH** .?_P"$RTO_ )]=<_\ !%>__&:/^$RTO_GUUS_P M17O_ ,9KH** .?\ ^$RTO_GUUS_P17O_ ,9H_P"$RTO_ )]=<_\ !%>__&:Z M"B@#C[?6;75_B'I?V:*^C\K2K[=]KL)[;.9;3&/-1=W3MG'&>HKL*Y^\_P"2 MAZ-_V"K_ /\ 1MI704 <_9_\E#UG_L%6'_HV[KH*Y^S_ .2AZS_V"K#_ -&W M==!0 4444 %%%% !1110 4444 %9PT2T_MF]U-]TDEY:QVLL3X,91"Y'&._F M-G)(Z5HT4 F\34+[3[B2V-I-)9L@,T).=C;U; M&"6PRX8;C@\TZ;P[##K)])U&RNKR]NIK^1)9KV5D$V]-OELNU0H*%%(&W&1D@Y.0>#K/\ LE[- MKV]:Y>\%^VH%D$YN 1M?A G 55QMV[1@@\UT5% %#1])@T73A9P22R_O'EDF MF(+RR.Q9G8@ 9))Z = !5^BB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** .?O/^2AZ-_P!@J_\ _1MI705S]Y_R4/1O^P5?_P#HVTKH* ./ MN-=T?1/B'JG]K:K8V'G:58^7]KN$BWXEN\XW$9QD=/45H?\ "=^#_P#H:]#_ M /!C#_\ %5T%% '/_P#"=^#_ /H:]#_\&,/_ ,51_P )WX/_ .AKT/\ \&,/ M_P 57044 <__ ,)WX/\ ^AKT/_P8P_\ Q5'_ G?@_\ Z&O0_P#P8P__ !5= M!10!S_\ PG?@_P#Z&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\ %5T%% '/ M_P#"=^#_ /H:]#_\&,/_ ,51_P )WX/_ .AKT/\ \&,/_P 57044 <__ ,)W MX/\ ^AKT/_P8P_\ Q5'_ G?@_\ Z&O0_P#P8P__ !5=!10!S_\ PG?@_P#Z M&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\ %5T%% '/_P#"=^#_ /H:]#_\ M&,/_ ,51_P )WX/_ .AKT/\ \&,/_P 57044 <__ ,)WX/\ ^AKT/_P8P_\ MQ5'_ G?@_\ Z&O0_P#P8P__ !5=!10!S_\ PG?@_P#Z&O0__!C#_P#%4?\ M"=^#_P#H:]#_ /!C#_\ %5T%% '/_P#"=^#_ /H:]#_\&,/_ ,51_P )WX/_ M .AKT/\ \&,/_P 57044 <__ ,)WX/\ ^AKT/_P8P_\ Q5'_ G?@_\ Z&O0 M_P#P8P__ !5=!10!P=KXT\*KXZU:X;Q+HP@?3+)$D-_%M9EENBP!W8) 921V MW#UK<_X3OP?_ -#7H?\ X,8?_BJZ"B@#G_\ A._!_P#T->A_^#&'_P"*H_X3 MOP?_ -#7H?\ X,8?_BJZ"B@#G_\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7 MH?\ X,8?_BJZ"B@#G_\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8? M_BJZ"B@#G_\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJZ"B@# MG_\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJZ"B@#G_\ A._! M_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJZ"B@#G_\ A._!_P#T->A_ M^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJZ"B@#G_\ A._!_P#T->A_^#&'_P"* MH_X3OP?_ -#7H?\ X,8?_BJZ"B@#G_\ A._!_P#T->A_^#&'_P"*H_X3OP?_ M -#7H?\ X,8?_BJZ"B@#G_\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ MX,8?_BJZ"B@#G_\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJZ L"B@#C[?7='UOXAZ7_9.JV-_Y.E7WF?9+A)=F9;3&=I.,X/7T-=A110!__]D! end GRAPHIC 7 image_006.jpg GRAPHIC begin 644 image_006.jpg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end GRAPHIC 8 image_007.jpg GRAPHIC begin 644 image_007.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#VO5?$&GZ- M<6]O=_:VGN$=XH[6RFN6*H5#$B)&( +H,G'453_X3+2_^?77/_!%>_\ QFB\ M_P"2AZ-_V"K_ /\ 1MI69\0[K[-%X>62?4(K:?5TBN!I[S++(GD3':/)^\L[:PBU62>.4RR$)(0TX,GE@M'U&,A\59C\3W5CK.JV[V.6QU$2RV\C;L+*FU'C=2HRI4J>1D\BNA\.ZJ=<\-Z;JK1B-KNV2 M9D!R%8J"1^!R* *7_"9:7_SZZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,UT% M% '/_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_ .,UT%% '/\ _"9: M7_SZZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,UT%% '/_P#"9:7_ ,^NN?\ M@BO?_C-'_"9:7_SZZY_X(KW_ .,UT%% '/\ _"9:7_SZZY_X(KW_ .,T?\)E MI?\ SZZY_P""*]_^,UT%% '/_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X M(KW_ .,UT%% '/\ _"9:7_SZZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,UT% M% '/_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_ .,UT%% '-GQSHJW M"6[1:R)W1G2,Z)>[F52 Q \K) +*">VX>M2?\)EI?_/KKG_@BO?_ (S1>?\ M)0]&_P"P5?\ _HVTJOXTN+G3(](UJ"XEC@L=0C^V1K(0DD$O[IMRC@[2ZOST MVGIUH L?\)EI?_/KKG_@BO?_ (S1_P )EI?_ #ZZY_X(KW_XS6&OB&>WU3Q! MK6Z:YA%[!HNFV7G%8Y)@0K,>H7,DA4M@D"(\'I3;[Q)?7FIZ+9RQ/IU];>($ MM+V&"X+QR(UK+(N'PN]""AP5&"O3@$@&]_PF6E_\^NN?^"*]_P#C-'_"9:7_ M ,^NN?\ @BO?_C-9UMX\^T:;H=Y_9NW^U+2YN=GGY\KREW;<[><^O&/>J,?C M_69H%>/PW;;I=*&KQ!M3('D8Y#'RCA_NX !!R:_\ M&7VOPR6B/H\_GEM.U$74$Z(H9UW*%R"C,NUU!#88#A37< @@$'(/0B@# _X3 M+2_^?77/_!%>_P#QFC_A,M+_ .?77/\ P17O_P 9KH** .?_ .$RTO\ Y]=< M_P#!%>__ !FC_A,M+_Y]=<_\$5[_ /&:Z"B@#G_^$RTO_GUUS_P17O\ \9H_ MX3+2_P#GUUS_ ,$5[_\ &:Z"B@#G_P#A,M+_ .?77/\ P17O_P 9H_X3+2_^ M?77/_!%>_P#QFN@HH Y__A,M+_Y]=<_\$5[_ /&:/^$RTO\ Y]=<_P#!%>__ M !FN@HH Y_\ X3+2_P#GUUS_ ,$5[_\ &:/^$RTO_GUUS_P17O\ \9KH** . M?_X3+2_^?77/_!%>_P#QFC_A,M+_ .?77/\ P17O_P 9KH** ,.V\6Z5=7]M M9*NI0SW3E(?M6EW,"NP1G(#21JN=J,<9[&MRN?\ $/\ R'/"?_85D_\ 2*ZK MH* "BBB@#G[S_DH>C?\ 8*O_ /T;:5H:GH]OJL^FRSO*K:?=B[B"$ ,X1TPV M0>,.>F.<WURTBMKEY42*YAN5,9 .Z- MPZ@Y!XRHS[>E9UYX.L+R[O;S[1=PW=S=0W:3QLFZWECC\M60%2/NY!#!@=QK MH:* .6X+3;?O)*9"P8D'>#CG,@(QBNDHH Y<>';G1UN]3M+N^UC M6!9_9+,WSQ#RUSD LJ+D;MI8MN;"\9/!VM%TR/1=#L-+A=GCM($@5VZMM4#) M]SC-7J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y^\_Y*'HW M_8*O_P#T;:5JZKIMOK&DWFF7:EK:[A>"4*<':P(.#V/-95Y_R4/1O^P5?_\ MHVTKH* .?C\'Z=%X4@\/+)<^1 RR1W)<&=9E?S!-NQ@OO^;)&"#M/ACB19KHB+2?[(&67_4\ M?-]W[_'7I[5T-% ',-X(M4,1LM5U2P(M(K.2A*L 6&Y"K<]> M!A\FA3_VSJL:27,5EJD$;FYMIMDMO/& F$ MG&DW]E#-H7MR8E80A0K$A%0?<4H-JYRX)XR1U]%% !1110 4444 M %%%% !1110 4444 %%%% !1110!S_B'_D.>$_\ L*R?^D5U705S_B'_ )#G MA/\ ["LG_I%=5T% !1110!R>O:MINC>.M$N-4U"TL8&TR^19+J98E+>;:' + M$#. 3CV-7/\ A._!_P#T->A_^#&'_P"*HO/^2AZ-_P!@J_\ _1MI704 <_\ M\)WX/_Z&O0__ 8P_P#Q5'_"=^#_ /H:]#_\&,/_ ,57044 <_\ \)WX/_Z& MO0__ 8P_P#Q5'_"=^#_ /H:]#_\&,/_ ,57044 <_\ \)WX/_Z&O0__ 8P M_P#Q5'_"=^#_ /H:]#_\&,/_ ,57044 <_\ \)WX/_Z&O0__ 8P_P#Q5'_" M=^#_ /H:]#_\&,/_ ,57044 <_\ \)WX/_Z&O0__ 8P_P#Q5'_"=^#_ /H: M]#_\&,/_ ,5705Q'C#Q+JF@>*-(:V(DTM+2YNM2@" NT2-$I=3C.4$A? Z@$ M=<4 :_\ PG?@_P#Z&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\ %5S^H>)] M32_U%;:]4P1^(--LX2J(P\B9+".*Z'PKJ5WJ2:P;N7S#;ZK M<6\7R@;8U(VC@07\6U6:6U*@G=@$A6('?:?2MS_ (3OP?\ ]#7H?_@QA_\ BJ+S_DH>C?\ M8*O_ /T;:57\<:O/I5AIL=O>7-I)>ZA';F6UM_/E";6=]B;'R=J$?=/6@"Q_ MPG?@_P#Z&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\ %5;\.WEO?:-%-;:I M/J:;F4W%Q&LA_^#&'_P"*H_X3OP?_ -#7 MH?\ X,8?_BJY>+Q5J^A:;?7&HWO]I2?\(\-8B$D21A)1G=&-@'[O)3&ZC#KM_H>IZC)J+PVEM>1W,L<:-^\WJR8157 :/(XS\Q!)Q0!:_X3OP M?_T->A_^#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN@HH Y_\ X3OP?_T->A_^ M#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN@HH Y_\ X3OP?_T->A_^#&'_ .*H M_P"$[\'_ /0UZ'_X,8?_ (JN@HH Y_\ X3OP?_T->A_^#&'_ .*H_P"$[\'_ M /0UZ'_X,8?_ (JN@HH Y_\ X3OP?_T->A_^#&'_ .*H_P"$[\'_ /0UZ'_X M,8?_ (JN@HH Y_\ X3OP?_T->A_^#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN M@HH Y_\ X3OP?_T->A_^#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN@HH Y_\ MX3OP?_T->A_^#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN@HH Y_\ X3OP?_T- M>A_^#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN@HH XO4/$N@ZSXD\*V^EZWIM M].NIR.T=K=)*P7['?\E#T;_L%7_\ Z-M*Z"N?O/\ DH>C?]@J_P#_ $;:5T% !1110 4444 % M%%% !1110 5E7.BBY\366L-,-MM:3VI@*9#^8T;9SGC'EXQCG/M6K10!P]E\ M.(M/M[BVM]2<6[ZQ;:E$CQ9\E(3'M@!W/#+ISM( Y!90XF Z#@[?P-=/10 4444 %%%% !1110 4444 %%%% M'/WG_)0]&_[!5_\ ^C;2M'5+;4;B&(Z9J*64\;[B9;<31R#!!5ERK8YR"K*< M@=1D'.O/^2AZ-_V"K_\ ]&VE=!0!S^D:/>Z&D,$4Z7)NKF:YU&X:/9EW!.4& M[Y1NV@#YN.ISR:R^%+V]OX)]=UA-0CM89H;=8[00,1(NUFE(8AFV\?*J#DG' M3'4T4 =PX&*WJ* "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** .?\0_\ASPG_V%9/\ TBNJZ"N? M\0_\ASPG_P!A63_TBNJZ"@ HHHH Y^\_Y*'HW_8*O_\ T;:5T%9^IZ%H^M^5 M_:VE6-_Y.?+^UVZ2[,XSC<#C.!T]!6?_ ,()X/\ ^A4T/_P70_\ Q- '045S M_P#P@G@__H5-#_\ !=#_ /$T?\()X/\ ^A4T/_P70_\ Q- '045S_P#P@G@_ M_H5-#_\ !=#_ /$T?\()X/\ ^A4T/_P70_\ Q- '045S_P#P@G@__H5-#_\ M!=#_ /$T?\()X/\ ^A4T/_P70_\ Q- '045S_P#P@G@__H5-#_\ !=#_ /$T M?\()X/\ ^A4T/_P70_\ Q- '045S_P#P@G@__H5-#_\ !=#_ /$T?\()X/\ M^A4T/_P70_\ Q- '045S_P#P@G@__H5-#_\ !=#_ /$T?\()X/\ ^A4T/_P7 M0_\ Q- '045S_P#P@G@__H5-#_\ !=#_ /$T?\()X/\ ^A4T/_P70_\ Q- ' M045S_P#P@G@__H5-#_\ !=#_ /$T?\()X/\ ^A4T/_P70_\ Q- '045S_P#P M@G@__H5-#_\ !=#_ /$T?\()X/\ ^A4T/_P70_\ Q- '045S_P#P@G@__H5- M#_\ !=#_ /$T?\()X/\ ^A4T/_P70_\ Q- '045S_P#P@G@__H5-#_\ !=#_ M /$T?\()X/\ ^A4T/_P70_\ Q- !>?\ )0]&_P"P5?\ _HVTKH*Y_P#X03P? M_P!"IH?_ (+H?_B:/^$$\'_]"IH?_@NA_P#B: .@HKG_ /A!/!__ $*FA_\ M@NA_^)H_X03P?_T*FA_^"Z'_ .)H Z"BN?\ ^$$\'_\ 0J:'_P""Z'_XFC_A M!/!__0J:'_X+H?\ XF@#H**Y_P#X03P?_P!"IH?_ (+H?_B:/^$$\'_]"IH? M_@NA_P#B: .@HKG_ /A!/!__ $*FA_\ @NA_^)H_X03P?_T*FA_^"Z'_ .)H M Z"BN?\ ^$$\'_\ 0J:'_P""Z'_XFC_A!/!__0J:'_X+H?\ XF@#H**Y_P#X M03P?_P!"IH?_ (+H?_B:/^$$\'_]"IH?_@NA_P#B: .@HKG_ /A!/!__ $*F MA_\ @NA_^)H_X03P?_T*FA_^"Z'_ .)H Z"BN?\ ^$$\'_\ 0J:'_P""Z'_X MFC_A!/!__0J:'_X+H?\ XF@#H**Y_P#X03P?_P!"IH?_ (+H?_B:/^$$\'_] M"IH?_@NA_P#B: .@HKG_ /A!/!__ $*FA_\ @NA_^)H_X03P?_T*FA_^"Z'_ M .)H Z"BN?\ ^$$\'_\ 0J:'_P""Z'_XFC_A!/!__0J:'_X+H?\ XF@ \0_\ MASPG_P!A63_TBNJZ"L>Q\)^&],O([RP\/Z5:74>=DT%E'&ZY!!PP&1D$C\:V (* "BBB@#_]D! end GRAPHIC 9 image_008.jpg GRAPHIC begin 644 image_008.jpg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end GRAPHIC 10 image_009.jpg GRAPHIC begin 644 image_009.jpg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end GRAPHIC 11 image_010.jpg GRAPHIC begin 644 image_010.jpg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end GRAPHIC 12 image_011.jpg GRAPHIC begin 644 image_011.jpg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end GRAPHIC 13 image_012.jpg GRAPHIC begin 644 image_012.jpg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end GRAPHIC 14 image_013.jpg GRAPHIC begin 644 image_013.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#VO5?$&GZ- M<6]O=_:VGN$=XH[6RFN6*H5#$B)&( +H,G'453_X3+2_^?77/_!%>_\ QFB\ M_P"2AZ-_V"K_ /\ 1MI69\0[K[-%X>62?4(K:?5TBN!I[S++(GD3':/)^\L[:PBU62>.4RR$)(0TX,GE@M'U&,A\59C\3W5CK.JV[V.6QU$2RV\C;L+*FU'C=2HRI4J>1D\BNA\.ZJ=<\-Z;JK1B-KNV2 M9D!R%8J"1^!R* *7_"9:7_SZZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,UT% M% '/_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_ .,UT%% '/\ _"9: M7_SZZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,UT%% '/_P#"9:7_ ,^NN?\ M@BO?_C-'_"9:7_SZZY_X(KW_ .,UT%% '/\ _"9:7_SZZY_X(KW_ .,T?\)E MI?\ SZZY_P""*]_^,UT%% '/_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X M(KW_ .,UT%% '/\ _"9:7_SZZY_X(KW_ .,T?\)EI?\ SZZY_P""*]_^,UT% M% '/_P#"9:7_ ,^NN?\ @BO?_C-'_"9:7_SZZY_X(KW_ .,UT%% '-GQSHJW M"6[1:R)W1G2,Z)>[F52 Q \K) +*">VX>M2?\)EI?_/KKG_@BO?_ (S1>?\ M)0]&_P"P5?\ _HVTJOXTN+G3(](UJ"XEC@L=0C^V1K(0DD$O[IMRC@[2ZOST MVGIUH L?\)EI?_/KKG_@BO?_ (S1_P )EI?_ #ZZY_X(KW_XS6&OB&>WU3Q! MK6Z:YA%[!HNFV7G%8Y)@0K,>H7,DA4M@D"(\'I3;[Q)?7FIZ+9RQ/IU];>($ MM+V&"X+QR(UK+(N'PN]""AP5&"O3@$@&]_PF6E_\^NN?^"*]_P#C-'_"9:7_ M ,^NN?\ @BO?_C-9UMX\^T:;H=Y_9NW^U+2YN=GGY\KREW;<[><^O&/>J,?C M_69H%>/PW;;I=*&KQ!M3('D8Y#'RCA_NX !!R:_\ M&7VOPR6B/H\_GEM.U$74$Z(H9UW*%R"C,NUU!#88#A37< @@$'(/0B@# _X3 M+2_^?77/_!%>_P#QFC_A,M+_ .?77/\ P17O_P 9KH** .?_ .$RTO\ Y]=< M_P#!%>__ !FC_A,M+_Y]=<_\$5[_ /&:Z"B@#G_^$RTO_GUUS_P17O\ \9H_ MX3+2_P#GUUS_ ,$5[_\ &:Z"B@#G_P#A,M+_ .?77/\ P17O_P 9H_X3+2_^ M?77/_!%>_P#QFN@HH Y__A,M+_Y]=<_\$5[_ /&:/^$RTO\ Y]=<_P#!%>__ M !FN@HH Y_\ X3+2_P#GUUS_ ,$5[_\ &:/^$RTO_GUUS_P17O\ \9KH** . M?_X3+2_^?77/_!%>_P#QFC_A,M+_ .?77/\ P17O_P 9KH** ,.V\6Z5=7]M M9*NI0SW3E(?M6EW,"NP1G(#21JN=J,<9[&MRN?\ $/\ R'/"?_85D_\ 2*ZK MH* "BBB@#G[S_DH>C?\ 8*O_ /T;:5H:GH]OJL^FRSO*K:?=B[B"$ ,X1TPV M0>,.>F.<WURTBMKEY42*YAN5,9 .Z- MPZ@Y!XRHS[>E9UYX.L+R[O;S[1=PW=S=0W:3QLFZWECC\M60%2/NY!#!@=QK MH:* .6X+3;?O)*9"P8D'>#CG,@(QBNDHH Y<>';G1UN]3M+N^UC M6!9_9+,WSQ#RUSD LJ+D;MI8MN;"\9/!VM%TR/1=#L-+A=GCM($@5VZMM4#) M]SC-7J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y^\_Y*'HW M_8*O_P#T;:5JZKIMOK&DWFF7:EK:[A>"4*<':P(.#V/-95Y_R4/1O^P5?_\ MHVTKH* .?C\'Z=%X4@\/+)<^1 RR1W)<&=9E?S!-NQ@OO^;)&"#M/ACB19KHB+2?[(&67_4\ M?-]W[_'7I[5T-% ',-X(M4,1LM5U2P(M(K.2A*L 6&Y"K<]> M!A\FA3_VSJL:27,5EJD$;FYMIMDMO/& F$ MG&DW]E#-H7MR8E80A0K$A%0?<4H-JYRX)XR1U]%% !1110 4444 M %%%% !1110 4444 %%%% !1110!S_B'_D.>$_\ L*R?^D5U705S_B'_ )#G MA/\ ["LG_I%=5T% !1110!R>O:MINC>.M$N-4U"TL8&TR^19+J98E+>;:' + M$#. 3CV-7/\ A._!_P#T->A_^#&'_P"*HO/^2AZ-_P!@J_\ _1MI704 <_\ M\)WX/_Z&O0__ 8P_P#Q5'_"=^#_ /H:]#_\&,/_ ,57044 <_\ \)WX/_Z& MO0__ 8P_P#Q5'_"=^#_ /H:]#_\&,/_ ,57044 <_\ \)WX/_Z&O0__ 8P M_P#Q5'_"=^#_ /H:]#_\&,/_ ,57044 <_\ \)WX/_Z&O0__ 8P_P#Q5'_" M=^#_ /H:]#_\&,/_ ,57044 <_\ \)WX/_Z&O0__ 8P_P#Q5'_"=^#_ /H: M]#_\&,/_ ,5705Q'C#Q+JF@>*-(:V(DTM+2YNM2@" NT2-$I=3C.4$A? Z@$ M=<4 :_\ PG?@_P#Z&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\ %5S^H>)] M32_U%;:]4P1^(--LX2J(P\B9+".*Z'PKJ5WJ2:P;N7S#;ZK M<6\7R@;8U(VC@07\6U6:6U*@G=@$A6('?:?2MS_ (3OP?\ ]#7H?_@QA_\ BJ+S_DH>C?\ M8*O_ /T;:57\<:O/I5AIL=O>7-I)>ZA';F6UM_/E";6=]B;'R=J$?=/6@"Q_ MPG?@_P#Z&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\ %5;\.WEO?:-%-;:I M/J:;F4W%Q&LA_^#&'_P"*H_X3OP?_ -#7 MH?\ X,8?_BJY>+Q5J^A:;?7&HWO]I2?\(\-8B$D21A)1G=&-@'[O)3&ZC#KM_H>IZC)J+PVEM>1W,L<:-^\WJR8157 :/(XS\Q!)Q0!:_X3OP M?_T->A_^#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN@HH Y_\ X3OP?_T->A_^ M#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN@HH Y_\ X3OP?_T->A_^#&'_ .*H M_P"$[\'_ /0UZ'_X,8?_ (JN@HH Y_\ X3OP?_T->A_^#&'_ .*H_P"$[\'_ M /0UZ'_X,8?_ (JN@HH Y_\ X3OP?_T->A_^#&'_ .*H_P"$[\'_ /0UZ'_X M,8?_ (JN@HH Y_\ X3OP?_T->A_^#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN M@HH Y_\ X3OP?_T->A_^#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN@HH Y_\ MX3OP?_T->A_^#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN@HH Y_\ X3OP?_T- M>A_^#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN@HH XO4/$N@ZSXD\*V^EZWIM M].NIR.T=K=)*P7['?\E#T;_L%7_\ Z-M*Z"N?O/\ DH>C?]@J_P#_ $;:5T% !1110 4444 % M%%% !1110 5E7.BBY\366L-,-MM:3VI@*9#^8T;9SGC'EXQCG/M6K10!P]E\ M.(M/M[BVM]2<6[ZQ;:E$CQ9\E(3'M@!W/#+ISM( Y!90XF Z#@[?P-=/10 4444 %%%% !1110 4444 %%%% M'/WG_)0]&_[!5_\ ^C;2M'5+;4;B&(Z9J*64\;[B9;<31R#!!5ERK8YR"K*< M@=1D'.O/^2AZ-_V"K_\ ]&VE=!0!S^D:/>Z&D,$4Z7)NKF:YU&X:/9EW!.4& M[Y1NV@#YN.ISR:R^%+V]OX)]=UA-0CM89H;=8[00,1(NUFE(8AFV\?*J#DG' M3'4T4 =PX&*WJ* "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** .?\0_\ASPG_V%9/\ TBNJZ"N? M\0_\ASPG_P!A63_TBNJZ"@ HHHH Y^\_Y*'HW_8*O_\ T;:5T%9^IZ%H^M^5 M_:VE6-_Y.?+^UVZ2[,XSC<#C.!T]!6?_ ,()X/\ ^A4T/_P70_\ Q- '045S M_P#P@G@__H5-#_\ !=#_ /$T?\()X/\ ^A4T/_P70_\ Q- '045S_P#P@G@_ M_H5-#_\ !=#_ /$T?\()X/\ ^A4T/_P70_\ Q- '045S_P#P@G@__H5-#_\ M!=#_ /$T?\()X/\ ^A4T/_P70_\ Q- '045S_P#P@G@__H5-#_\ !=#_ /$T M?\()X/\ ^A4T/_P70_\ Q- '045S_P#P@G@__H5-#_\ !=#_ /$T?\()X/\ M^A4T/_P70_\ Q- '045S_P#P@G@__H5-#_\ !=#_ /$T?\()X/\ ^A4T/_P7 M0_\ Q- '045S_P#P@G@__H5-#_\ !=#_ /$T?\()X/\ ^A4T/_P70_\ Q- ' M045S_P#P@G@__H5-#_\ !=#_ /$T?\()X/\ ^A4T/_P70_\ Q- '045S_P#P M@G@__H5-#_\ !=#_ /$T?\()X/\ ^A4T/_P70_\ Q- '045S_P#P@G@__H5- M#_\ !=#_ /$T?\()X/\ ^A4T/_P70_\ Q- '045S_P#P@G@__H5-#_\ !=#_ M /$T?\()X/\ ^A4T/_P70_\ Q- !>?\ )0]&_P"P5?\ _HVTKH*Y_P#X03P? M_P!"IH?_ (+H?_B:/^$$\'_]"IH?_@NA_P#B: .@HKG_ /A!/!__ $*FA_\ M@NA_^)H_X03P?_T*FA_^"Z'_ .)H Z"BN?\ ^$$\'_\ 0J:'_P""Z'_XFC_A M!/!__0J:'_X+H?\ XF@#H**Y_P#X03P?_P!"IH?_ (+H?_B:/^$$\'_]"IH? M_@NA_P#B: .@HKG_ /A!/!__ $*FA_\ @NA_^)H_X03P?_T*FA_^"Z'_ .)H M Z"BN?\ ^$$\'_\ 0J:'_P""Z'_XFC_A!/!__0J:'_X+H?\ XF@#H**Y_P#X M03P?_P!"IH?_ (+H?_B:/^$$\'_]"IH?_@NA_P#B: .@HKG_ /A!/!__ $*F MA_\ @NA_^)H_X03P?_T*FA_^"Z'_ .)H Z"BN?\ ^$$\'_\ 0J:'_P""Z'_X MFC_A!/!__0J:'_X+H?\ XF@#H**Y_P#X03P?_P!"IH?_ (+H?_B:/^$$\'_] M"IH?_@NA_P#B: .@HKG_ /A!/!__ $*FA_\ @NA_^)H_X03P?_T*FA_^"Z'_ M .)H Z"BN?\ ^$$\'_\ 0J:'_P""Z'_XFC_A!/!__0J:'_X+H?\ XF@ \0_\ MASPG_P!A63_TBNJZ"L>Q\)^&],O([RP\/Z5:74>=DT%E'&ZY!!PP&1D$C\:V (* "BBB@#_]D! end